Cross-fund · 4 holders
GLUE
MONTE ROSA THERAPEUTICS INC
CUSIP 61225M102
4
Tracked holders
$152.0M
Aggregate value
9,393,684
Shares
4
Active funds
Funds holding GLUE
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $92.7M | — | +1,456,523 | +34.8% |
| Vanguard | Institutional | Q4 2025 | $50.9M | — | +257,547 | +8.6% |
| Citadel | Multi-Strategy | Q1 2026 | $5.2M | — | +233,655 | +276.6% |
| Millennium | Multi-Strategy | Q1 2026 | $3.1M | — | +87,410 | +84.1% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.